𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amplification of fgfr4 gene in human breast and gynecological cancers

✍ Scribed by Susanna Jaakkola; Paula Salmikangas; Stella Nylund; Pentti Lehtovirta; Heli Nevanlinna; Juha Partanen; Elina Armstrong; Seppo Pyrhönen

Publisher
John Wiley and Sons
Year
1993
Tongue
French
Weight
777 KB
Volume
54
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

We have investigated gene amplification of fibroblast growth factor receptor-4 (FGFM) gene in 30 primary breast tumor samples and 15 gynecological tumor samples. Ten percent of

📜 SIMILAR VOLUMES

Ras gene mutation and amplification in h
Ras gene mutation and amplification in human nonmelanoma skin cancers
✍ William E. Pierceall; Leonard H. Goldberg; Michael A. Tainsky; Tapas Mukhopadhya 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

Our previous studies have shown that human skin cancers occurring on sun-exposed body sites frequently contain activated Ha-ras oncogenes capable of inducing morphologic and tumorigenic transformation of NIH 3T3 cells. In this study, we analyzed human primary squamous cell carcinomas (SCCs) and basa

Expression of the FGFR1 gene in human br
Expression of the FGFR1 gene in human breast-carcinoma cells
✍ Jocelyne Jacquemier; José Adelaide; Patricia Parc; Frédérique Penault-Llorca; Ja 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 742 KB

Fibroblast growth factors (FGF) constitute a family of at least 9 members which act through high-affinity tyrosine-kinase receptors encoded by 4 distinct genes. In humans, the FGFRl gene is located in chromosomal region 8 ~1 2 . I t s amplification and expression were examined in a panel of I10 brea

Epigenetic silencing of maspin gene expr
Epigenetic silencing of maspin gene expression in human breast cancers
✍ Frederick E. Domann; Judd C. Rice; Mary J.C. Hendrix; Bernard W. Futscher 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB 👁 2 views

Maspin is a tumor suppressor whose expression is lost in many advanced breast cancers. Maspin has been shown to inhibit cell motility, invasion and metastasis; however, its precise role in normal mammary epithelium remains to be elucidated. Although expression of maspin mRNA is low or absent in most

Mutational analysis of the p73 Gene in h
Mutational analysis of the p73 Gene in human breast cancers
✍ Tomotane Shishikura; Shingo Ichimiya; Toshinori Ozaki; Yoshinori Nimura; Hajime 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB 👁 2 views

In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region

Characterization of topoisomerase IIα ge
Characterization of topoisomerase IIα gene amplification and deletion in breast cancer
✍ Tero A.H. Järvinen; Minna Tanner; Maarit Bärlund; Åke Borg; Jorma Isola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Topoisomerase II␣ (TOP2A) is a key enzyme in DNA replication and a molecular target for many important anticancer drugs. TOP2A is amplified or deleted together with amplification of the closely located ERBB2/HER-2/neu oncogene in breast cancer. We characterized the copy number aberrations of TOP2A a